Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-27T14:00:45.792Z Has data issue: false hasContentIssue false
  • English
  • Français

Motion Sickness: Comparison of Metoclopramide and Diphenhydramine to Placebo

Published online by Cambridge University Press:  11 October 2011

Stephanie Rubio ,
Lori Weichenthal  and
Jim Andrews
Stephanie Rubio
Affiliation:
Kaiser Permanente Medical Center, Fresno, California USA
Lori Weichenthal*
Affiliation:
Department of Emergency Medicine, UCSF-Fresno Medical Education Program, Community Regional Medical Center, Fresno California USA
Jim Andrews
Affiliation:
Department of Emergency Medicine, UCSF-Fresno Medical Education Program, Community Regional Medical Center, Fresno California USA
*
Correspondence: Lori Weichenthal, MD 155 North Fresno Street, Suite 206Fresno, California 93701-2302 USA E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: This is an evaluation of the efficacy of metoclopramide (MTCP) or diphenhydramine (DPH) to relieve symptoms of motion sickness in patients being transported via ambulance in a mountainous setting.

Methods: This is a prospective, randomized, double-blinded, placebo-controlled study of patients transported by ambulance in the Sierra Nevada mountains of Fresno County. Consenting patients who met the inclusion criteria were asked to rate their motion sickness every five minutes using a visual analog scale (VAS) during transport. If motion sickness occurred, they were randomized to receive MTCP (20 mg IV), DPH (50 mg IV), or placebo (normal saline), and remaining symptoms were recorded every five minutes. If signs and symptoms of motion sickness persisted after 15 minutes, a rescue dose of MTCP was offered.

Results: Twenty-six patients were enrolled in the study. Twenty-two (84.6%) developed motion sickness and were randomized to MTCP, DPH, or placebo. Eight patients received MTCP, seven received DPH, and seven received placebo. The MTCP group showed a statistically significant decrease in the mean VAS score at 15 minutes compared to the DPH and placebo groups. There was no significant difference in the decrease in VAS score between the placebo and the DPH group. Twelve out of 22 patients requested a rescue dose of MTCP after 15 minutes. At 25 minutes, there was no significant difference in the VAS score between the three groups.

Conclusion: During ambulance transport in a mountainous setting, the administration of MTCP is superior to both DPH and placebo in the treatment of motion sickness. Diphenhydramine is not superior to placebo.

Keywords

BenadrylMetoclopramidemotion sicknessprehospital
Type
Brief Report
Information
Prehospital and Disaster Medicine , Volume 26 , Issue 4 , August 2011 , pp. 305 - 309
Copyright
Copyright Rubio © World Association for Disaster and Emergency Medicine 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Turner, M, Griffin, MJ: Motion sickness in public road transport: Passenger behavior and susceptibility. Ergonomics 1999;42:444–461.CrossRefGoogle ScholarPubMed
Weichenthal, L, Soliz, T: The incidence and treatment of prehospital motion sickness. Prehospital Emerg Care 2003;7:474–476.CrossRefGoogle ScholarPubMed
Kober, A, Fleischakl, R, Scheck, T, Lieba, F, Strasser, H, Friedmann, A, Sessler, DIA: A randomized controlled trial of oxygen for reducing nausea and vomiting during emergency transport of patients older than 60 years with minor trauma. Mayo Clin Proc 2002;77:35–38.CrossRefGoogle ScholarPubMed
Fleischhackl, R, Dörner, C, Scheck, T, Fleischhackl, S, Hafez, J, Kober, A, Bertalanffy, P, Hoerauf, K: Reduction of motion sickness in prehospital trauma care. Anesthesia 223;58:363–384.Google Scholar
Bertalnanffy, P, Hoerauf, K, Strasser, H, et al: Korean hand acupressure for motion sickness in prehospital trauma care: A prospective, randomized, double-blinded trial in a geriatric population. Anesthesia 2004;98:220–223.Google Scholar
Wright, R, Anderson, A, Lesko, S, Woolf, A, Linakis, J, Lewander, W: Effect of MTCP dose on preventing emeisis after oral administration of N-Acetylcysteine for acetaminophen overdose. Clin Toxicol 1999;37:35–42.Google Scholar
Braude, D, Soliz, T, Cradall, C, Hendey, G, Andrews, J, Weichenthal, L: Antiemetics in the ED: A randomized controlled trial comparing three common agents. Am J Emerg Med 24:177–182.CrossRefGoogle Scholar